HDL Phospholipid: a Natural Inhibitor of Alzheimer’s Amyloid β-Fibrillogenesis?

Articles in the same Issue

1. Laboratory Variables as Additional Staging Parameters in Patients with Small-Cell Lung Carcinoma. A Systematic Review
2. High Density Lipoproteins (HDL) and the Oxidative Hypothesis of Atherosclerosis
3. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Standardization Project for the Measurement of Lipoprotein(a). Phase 2: Selection and Properties of a Proposed Secondary Reference Material for Lipoprotein(a).
4. Stem Cell Factor and Granulocyte-Macrophage-Colony Stimulating Factor as Candidates for Tumour Markers for Non-Small-Cell Lung Cancer
5. Concentrations of Plasma Methylmalonic Acid in 80-Year-Olds Show Only Weak Relation to Psychological Performance
6. The Risk Groups for Coronary Heart Disease in Koreans. Assessment by Distribution of Serum Lipid Concentrations
7. Serum Proteins by Capillary Zone Electrophoresis: Approaches to the Definition of Reference Values
8. Efficiency of Some In Vitro Allergy Tests for Evaluating Atopy in Children and Adults
9. Pre-metrological (Pre-analytical) Variation of Some Biochemical Quantities
10. Point-of-Care Testing
11. HDL Phospholipid: a Natural Inhibitor of Alzheimer’s Amyloid β-Fibrillogenesis?
12. Bailey & Scott’s Diagnostic Microbiology, 10th edition, by B. A. Forbes, D. F. Sahm and A. S. Weissfeld
13. Physical Chemistry for the Biomedical Sciences, by S.R. Logan